| NCT Number | NCT07485179 |
| Lead Sponsor | Brigham and Women's Hospital
Collaborators: Food and Drug Administration (FDA) |
| Conditions | Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) |
| Enrollment | 770 participants |
| Start Date | 2026-03-12 |
| Primary Completion | 2026-09-12 (estimated) |
| Study Completion | 2027-03-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-12 |